/DISREGARD RELEASE: Jiangsu Vcare/
View all comments(0)
We are advised by Jiangsu Vcare that journalists and other readers should disregard the news release, Jiangsu Vcare Files NDA for Vicagrel Capsules with US FDA, issued 04-Jan-2024 over PR Newswire.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
MixVio AI Launches Unified Creative Workspace Across 26 AI Generation Routes

Bitcoin, ETF holders tether hope to Uptober 2026 to return into gains after 10/10 crash

How Do Fed Rate Hikes Affect US Stocks? A Detailed Breakdown of the Logic

PLTR, CRM, NOW, SNOW Comparison: Palantir Leads Growth, Salesforce's AI ARR Is Clearer

Bloom Energy Stock Price Forecast: AI Data Center Power Shortages Boost Fuel Cell Demand, Stock Could Rise to $309








Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.